Ibrutinib + R-CHOP Followed by Ibrutinib Maintenance

NCT03731234 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

DLBCL

Interventions

DRUG: Ibrutinib

Sponsor

Fondazione Italiana Linfomi - ETS

Collaborators

[object Object]